Search Results (8,359)

Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. The present study aimed to evaluate the protective effects of a probiotic against experimentally induced gastric ulcers in rats. Male Wistar rats were allocated into five groups (n = 6 per group): Control, Model (indomethacin-induced ulcers, IND), Positive control (IND + famotidine), IND + Laktera Nature (LN) probiotic (800 mg/kg), and IND + LN probiotic (1600 mg/kg). The study duration was 14 days. On day 15, rats in groups 2–5 received 1 mL of indomethacin (40 mg/kg) orally. All rats were euthanized four hours later via cervical dislocation under diethyl ether anesthesia. LN probiotics have demonstrated dose-dependent protection against indomethacin-induced gastric ulcers, as assessed by both macroscopic and microscopic evaluation. Therefore, LN probiotics may represent a valuable adjunctive strategy in the management of gastric ulcers. Full article

Background/Objectives: Ejiao, a macromolecular protein complex derived from donkey hide, is a traditional Chinese medicine with clinically demonstrated efficacy against ulcerative colitis (UC). Due to its large molecular size and poor absorbability, its therapeutic effects are presumed to depend on gut microbiota. We hypothesized that specific gut bacteria capable of degrading Ejiao might also mediate its biological functions. Methods: To test this hypothesis, a systematic investigation was conducted by integrating culturomics, proteomics, metabolomics, 16S rRNA gene amplicon high-throughput sequencing, and animal disease models. Results: A total of 134 human gut bacterial strains capable of utilizing Ejiao as a nutrient source were isolated. Among them, Ligilactobacillus salivarius D3-8 exhibited the strongest growth in Ejiao-based medium. Genomic analysis identified 63 protease/peptidase genes, and peptidomic profiling confirmed its degradation activity, which released 50 novel peptides. Notably, administration of L. salivarius D3-8 alone significantly alleviated dextran sodium sulfate (DSS)-induced colitis, concurrently increasing the abundance of beneficial bacterium Dubosiella newyorkensis and elevating the anti-inflammatory metabolite indole-3-carbinol via upregulated tryptophan metabolism. Conclusions: Our findings identify L. salivarius D3-8 as both a dedicated Ejiao-degrader and a protective probiotic against colitis. This work provides direct evidence that gut bacteria can utilize Ejiao and proposes a potential novel mechanistic framework in which the biological effects of Ejiao may be mediated through its interaction with specific, functionally potent degraders such as L. salivarius D3-8. Full article

Industrial spore production of the probiotic Heyndrickxia coagulans is hindered by its generally low and highly variable sporulation efficiency across strains. To address this, we selected the representative model strain ATCC 7050 and applied an integrated strategy combining statistical medium optimization with genomic analysis. Key factors (glucose, yeast extract, CaCl₂) were screened and optimized using Plackett–Burman and Box–Behnken designs, yielding an optimal formulation that achieved 1.84 × 10⁸ spores/mL in a bioreactor, consistent with the model prediction. Further genomic analysis revealed 112 sporulation-associated genes and identified key homologous genes related to spore resistance and germination. Among them, the successful identification of spoVA, which is implicated in calcium-dipicolinate transport in bacilli, allowed us to hypothesize why calcium ions play a critical role. This work not only enhances the spore yield of a model strain but also provides a framework to tackle the widespread sporulation variability in H. coagulans for industrial applications. Full article

Enteropathogenic Escherichia coli (EPEC) disrupts intestinal barrier integrity, induces inflammation, and alters gut microbial balance, leading to diarrhea and growth impairment. Probiotics are considered promising alternatives to antibiotics for managing enteric infections, yet the functional properties and underlying mechanisms of feline-derived strains remain unclear. This study evaluated the protective effects of Ligilactobacillus (L.) agilis ZY25 and L. salivarius ZY35, isolated from healthy cats, against EPEC-induced intestinal injury in C57BL/6 mice, with a focus on barrier function, immune modulation, and microbial homeostasis. In this 21-day experiment, 48 mice were assigned to six groups (n = 8/group): control, EPEC model (MOD), chlortetracycline treatment (CTC), probiotic treatment (PRO-T; post-infection only), probiotic pre-treatment (PRO-P; pre-infection only), and continuous probiotic supplementation (PRO; pre- and post-infection). EPEC challenge (0.2 mL; 1 × 10⁹ CFU/mL) was performed daily during experimental days 8–14. EPEC challenge resulted in weight loss (p < 0.05), increased (p < 0.05) diarrhea incidence, elevated (p < 0.05) serum D-lactate, diamine oxidase, and lipopolysaccharide levels, impaired intestinal morphology, immune imbalance, and microbial dysbiosis. Probiotic administration alleviated these alterations, as evidenced by restored intestinal morphology, reduced serum markers of barrier permeability (D-lactate, DAO, LPS), enhanced systemic immunoglobulins (IgA, IgG, IgM), a balanced cytokine profile (increased IL-4, IL-10; decreased TNF-α, IL-6, IL-1β, IFN-γ, CRP), and modulation of the gut microbiota (enrichment of beneficial taxa such as Lachnospiraceae_NK4A136_group and suppression of pro-inflammatory Desulfovibrio). The continuous supplementation regimen (PRO) produced the most consistent improvements among the three intervention strategies tested. These findings suggest that feline-derived probiotics mitigate EPEC-induced intestinal dysfunction, accompanied by improved barrier-related indices, immune rebalancing, and microbial stabilization, thereby providing proof-of-concept evidence for their further evaluation in feline gastrointestinal health. Full article

Gut microbiota dysbiosis is implicated in metabolic disorders, yet taxonomic and functional alterations in canine diabetes remain incompletely defined. Here, we performed shotgun metagenomic sequencing of fecal samples from 38 diabetic dogs and 37 healthy controls under controlled conditions (no recent antibiotic/probiotic exposure and stable commercial diets). Alpha-diversity indices did not differ between groups, whereas beta-diversity revealed significant separation of community structure at both genus and species levels (p < 0.05). Linear discriminant analysis effect size (LEfSe) identified enrichment of opportunistic-associated taxa in diabetic dogs, including Enterobacterales/Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae, Salmonella enterica) and Enterococcus faecalis. In contrast, healthy dogs were enriched for putatively beneficial taxa linked to bile acid and short-chain fatty acid (SCFA) metabolism, including Turicibacter spp. and Romboutsia spp. Functional profiling showed higher abundances of pathways related to carbohydrate/energy metabolism, membrane transport, and virulence/colonization in diabetic dogs; 17 KEGG level-3 pathways and 320 KOs differed at FDR < 0.05, with enriched modules including bacterial secretion systems, lipopolysaccharide biosynthesis, chemotaxis/flagellar assembly, and biofilm formation. Collectively, canine diabetes is associated with a remodeled gut microbiome characterized by expansion of opportunistic pathogens and elevated virulence and metabolic potential, supporting exploration of microbiota-targeted strategies as a complement to conventional management. Full article

The study aimed to determine the effect of newly developed multi-strain synbiotics on the hygienic quality of feed for pigs and pork edible raw materials originating from animals supplemented with synbiotics. The trial was conducted on 54 feed samples and 54 pigs. Animals were divided into six groups corresponding to three synbiotic preparations (A, B, C), two positive controls with probiotics (D, E), and a negative control (K) with no feed additive. The supplementation of the sow’s basal diet with the feed additive started 10 days before farrowing and continued for 38 days, covering the lactation period. The diet of piglets from groups A-E was supplemented with the feed additive starting from two weeks of age until slaughter at 24 weeks of age. Feed and animal raw materials were tested for the presence of Salmonella spp., Campylobacter spp., L. monocytogenes, Clostridium spp., C. perfringens, C. botulinum, and the count of AMB, TPC, fungi, ASFB, C. perfringens, Enterobacteriaceae family, E. coli, presumptive B. cereus, CoPS, HS, LAB, yeast probiotic strains, and Enterococcus spp. Statistically significant differences were found between individual groups in the count of C. perfringens, AMB, TPC, Enterococcus spp., and LAB in all feeds tested. Moreover, synbiotics A, B, and C lowered the count of AMB, TPC, and LAB, and synbiotics A and C decreased Enterobacteriaceae family contamination in both total raw materials as well as raw materials of fatteners. The higher effectiveness of synbiotics was associated with a higher number of probiotic strains in one preparation. Our study found that dietary supplementation of synbiotics alters the occurrence of C. perfringens in feed and enhances the hygienic quality of edible pork raw materials. Full article

Encapsulated probiotics, which are promising approaches for improving aquaculture species’ performance and health, have incompletely characterized dose-dependent physiological and immunological effects. This study represents the first report evaluating the probiotic efficacy of a novel encapsulated Lysinibacillus sp. PWR01, originally isolated from rubber latex nodules, in Nile tilapia (Oreochromis niloticus). A total of 300 Nile tilapia (10.80 ± 0.07 g) was allocated to four experimental groups receiving 0, 10⁴, 10⁵, and 10⁶ CFU/g of encapsulated Lysinibacillus sp. PWR01 in their diet. At 8 weeks of the feeding trial, growth performance, feed utilization, serum antioxidant status, intestinal bacterial counts and immune-related gene expression were analyzed. Results demonstrated that fish fed 10⁶ CFU/g achieved a final weight of 51.48 g, representing a 9.88% increase compared with the control (46.85 g), while weight gain (WG) improved by 12.82% and specific growth rate (SGR) by 6.34%. Feed conversion ratio (FCR) was reduced by up to 18.42% at 10⁵ CFU/g relative to the control. Encapsulated groups enhanced serum superoxide dismutase activity without altering malondialdehyde levels, increased total intestinal bacterial and lactic acid bacteria counts, and selectively upregulated TLR2 and MHC II mRNA transcript levels. Histological analysis further revealed increased intestinal villus height and width in encapsulated-fed groups, while liver architecture remained normal across treatments. Multivariate analyses demonstrated strong positive associations among growth performance, gut microbiota enrichment, and immune gene expression. Resistance to Aeromonas hydrophila infection was significantly improved at higher dietary doses, with post-challenge survival reaching 61.67–75% in supplemented groups versus 45.00% in controls. These findings demonstrate that latex-derived Lysinibacillus sp. PWR01 acts as a strain-specific immunomodulatory probiotic that enhances growth, antioxidant capacity, microbial community balance, and disease resistance to Nile tilapia. Future studies should investigate the role of the Nrf2 antioxidant pathway, clarify TLR2-mediated immune signaling, and assess gut microbiota–immune system interactions within commercial-scale production systems. Full article

Cancer remains a leading cause of death worldwide, and current treatments are often limited by toxicity and resistance. Emerging research highlights the crucial roles played by gut microbiome dysbiosis and oxidative stress in cancer development and treatment response. Through their antioxidant, anti-inflammatory, and immunomodulatory properties, natural antioxidants such as resveratrol, along with microbiome modulators like probiotics, prebiotics, and synbiotics, offer promising therapeutic benefits. However, issues such as low bioavailability, instability, and challenges related to targeted delivery hinder the clinical translation of these bioactive compounds. Next-generation hydrogels have emerged as adaptable platforms capable of delivering and protecting these agents in a site-specific and controlled manner. This review summarizes the design and synthesis of multifunctional hydrogels incorporating natural antioxidants and microbiome modulators for cancer therapy. Full article

During the last few decades, an urgent need for sustainable and health-promoting food products has been witnessed. In this vein, the development of functional foods enriched with probiotics has gained considerable interest from both the food industry and consumers. However, the maintenance of high cell viability until the time of consumption remains a significant challenge. In this study, freeze-dried immobilized Lacticaseibaciilus paracasei FBM_1327 cells on sunflower seeds were evaluated as a functional food ingredient, and their ability to survive during simulated digestion and storage at ambient and refrigerated temperatures in comparison to free cells was assessed. Cell immobilization resulted in higher survival rates (>70%) after in vitro digestion compared to free cells (<40%), while the freeze-dried immobilized cells maintained in cell levels >7.5 log cfu/g during storage for 6 months at 4 °C. In the next step, freeze-dried free or immobilized cells were incorporated in cream cheese (CCF and CCI samples, respectively) at a concentration of >8 log cfu/g. Cell viability of the immobilized cells remained stable (>8.1 log cfu/g) during storage, while live cell counts of free cells dropped to 7.51 ± 0.11 log cfu/g after 28 days. The fortification of cream cheese with immobilized L. paracasei FBM_1327 cells on sunflower seeds improved the volatile compounds profile, while all samples were accepted by the panel during the sensory evaluation. Full article

Fermented milk represents an excellent carrier for probiotics, and the incorporation of different carbon sources during fermentation can profoundly affect microbial metabolism. Based on our previous finding that Lactobacillus helveticus DYNDL_20-5 produces fucose-containing exopolysaccharides (EPS), we hypothesized that fucose supplementation could further enhance its metabolic activity and improve fermented milk quality. Thus, this study systematically investigated the impact of culturing L. helveticus DYNDL_20-5 with fucose (CMF5) on the quality characteristics and metabolic profiles of fermented milk. Compared to the control group without fucose and L. helveticus (CM), the CMF5 group demonstrated that L. helveticus effectively utilized fucose to promote acid production, enhance the fermentation process, increase microbial abundance, and enrich beneficial genera. Furthermore, the CMF5 group exhibited significantly improved textural properties, including enhanced viscosity and gel strength. Metabolomic analysis revealed that the addition of fucose and L. helveticus significantly influenced the metabolism of organic acids, fatty acids, and amino acids during milk fermentation, leading to increased concentrations of various metabolites associated with sensory quality, nutritional value, and health-promoting benefits. The findings of this study provide valuable insights into the synergistic effects of L. helveticus DYNDL_20-5 and fucose on fermented milk quality, offering a theoretical foundation for the development of novel functional dairy products with enhanced nutritional and sensory attributes. Full article

Background: Aquaculture, a vital component of global food security, faces sustainability challenges due to intensive farming practices, including water pollution, disease outbreaks, and antibiotic overuse. Probiotics, prebiotics, and synbiotics have emerged as eco-friendly alternatives to antibiotics. However, research results remain heterogeneous across aquatic species and intervention strategies. Methods: Following PRISMA 2020, we searched two databases (up to January 2026) for in vivo trials. Two reviewers screened and extracted data, and 177 eligible studies were ultimately included, covering single-/multi-strain probiotics (SSP/MSP), live/inactivated microbial preparations, and diverse synbiotic formulations. Results: Among 177 studies, Bacillus spp. were the most widely reported and effective probiotic strains. MSP and synbiotics exhibited superior efficacy in boosting aquatic animal growth performance and disease resistance over SSP in 68% of the included trials. Probiotics act through the competitive exclusion of pathogens, immune modulation, and enhanced digestive enzyme activity; prebiotics selectively stimulate beneficial gut microbiota, improving nutrient absorption and immune function through metabolites such as short-chain fatty acids; synbiotics combine the advantages of both, exerting synergistic effects. Furthermore, as water additives or fermented feed ingredients, probiotics reduce nitrogenous waste and organic pollutants, contributing to bioremediation. Conclusions: All three additives are effective. Standardized application protocols and long-term trials are needed for sustainable aquaculture. This review provides a unified evidence-based foundation for the rational use of these additives in aquaculture. Full article

The wine ecosystem constitutes a highly selective ecological niche characterized by low pH, high ethanol levels, sulfur dioxide, polyphenols, and nutrient limitation. During malolactic fermentation, this environment becomes dominated by specialized lactic acid bacteria (LAB), particularly Lactiplantibacillus plantarum and Oenococcus oeni, whose persistence under such stressors suggests the presence of adaptive traits relevant to probiotic development. In this study, twenty-three LAB isolates obtained from the spontaneous wine ecosystem were systematically evaluated through a multi-stage screening strategy. Primary single-factor assays revealed pronounced inter- and intraspecies variability in tolerance to acid, lysozyme, and bile salts. As a result, all O. oeni isolates and eight L. plantarum strains were excluded from further consideration. The four selected L. plantarum isolates (M-1, SY-2, XJA2, and XJ14) were subsequently subjected to simulated gastrointestinal challenges. Strains M-1 and XJ14 maintained high viability across both gastric and intestinal phases. In contrast, SY-2 and XJA2 exhibited pronounced gastric sensitivity but demonstrated strong survival in the intestinal phase. Functional characterization further distinguished the isolates: M-1 and XJ14 displayed balanced probiotic profiles, whereas XJA2 exhibited exceptional auto-aggregation and efficient metabolic capacity, suggesting specific colonization potential despite its gastric vulnerability. Comprehensive safety assessments confirmed the absence of hemolytic activity, biogenic amine production, and acquired antibiotic resistance in the tested isolates. Collectively, these findings identify M-1 and XJ14 as promising candidates for direct probiotic application, and XJA2 as a promising functional strain for encapsulation-based delivery. This study highlights the wine ecosystem as a valuable reservoir for novel probiotic development. Full article

This study aimed to evaluate effect of Gordonia alkanivorans on phagocytic activity of porcine alveolar macrophages (PAMs) and immune function in piglets. Quantitative PCR and fluorescence tracing were used to measure phagocytic efficiency of G. alkanivorans-intervened PAMs against PRRSV and E. coli. Sixty-four 45-day-old cross-bred piglets with equal sex were randomly divided into four groups (n = 16/group). Growth performance, immune function, and intestinal flora were analyzed. G. alkanivorans extract exhibited half cytotoxic concentration of 36.43 mg/mL, half effective concentration of 0.1009 mg/mL, and half inhibitory concentration of 0.0043 mg/mL in PAMs, significantly increasing their phagocytic efficiency by 98.5% against PRRSV and 2.31- to 13.46-fold against E. coli. Dietary supplementation with G. alkanivorans elevated antibody-positive rates against classical swine fever virus (47.92%) and pseudorabies virus (14.58%), modified serum cytokine: Interleukin (IL)-1β, IL-2, Tumor Necrosis Factor -α, Interferon (IFN)-α, IFN-γ, IL-4, and IL-10 (−144.51% to +191.72%). It increased intestinal operational taxonomic units by 152%, the Shannon index by 14.62%, and the Chao index by 11.37%, while reducing the Firmicutes/Bacteroidetes ratio by 713.90%. In conclusion, G. alkanivorans enhances immunity and antiviral activity in piglets by gut and immune regulation. Full article

Celiac disease (CD) is an autoimmune disorder triggered by immunogenic gluten peptides that resist gastrointestinal digestion. The only current treatment is a strict gluten-free diet, which is challenging to maintain. Lactic acid bacteria (LAB) with specific proteolytic systems offer a promising strategy for gluten hydrolysis and potential reduction of immunogenicity. This study aims to isolate and characterize gluten-degrading LAB from traditional Spanish and Algerian dairy products. A total of 27 artisanal dairy samples were collected. LAB were isolated on MRS and Elliker agar. Gluten-degrading activity was screened using a well diffusion assay with cell-free supernatants and a spot assay with live cultures. Active isolates were identified by 16S rRNA gene sequencing. Out of 123 isolates, 40 (32.5%) were positive in the well assay, while 67 (54.5%) were positive in the spot assay, indicating the latter’s higher sensitivity for detecting cell-associated proteases. Halo diameters ranged from 6 to 16 mm. Algerian isolates exhibited significantly stronger activity (mean halo: 12.6 ± 2.1 mm) compared to Spanish isolates (10.2 ± 2.0 mm; p < 0.001). Molecular identification of the 32 most active isolates revealed the following dominant species: Lactiplantibacillus plantarum, L. pentosus, Levilactobacillus brevis, and Enterococcus faecium. This study confirms that artisanal dairy fermentations are rich sources of LAB with robust gluten-degrading potential. The superior activity of Lactiplantibacillus spp. aligns with their complex peptidase systems. The geographical variation highlights the influence of local fermentation practices. Selected strains represent excellent candidates for developing adjunct cultures to produce gluten-reduced foods and warrant further investigation as potential probiotics, pending safety and efficacy validation in vivo and in clinical studies. Full article

Emerging evidence suggests that gut microbiota significantly influence female reproductive health by affecting hormonal, immune and metabolic processes. This research explored how a probiotic blend comprising Lactobacillus crispatus novaLCR6, Limosilactobacillus fermentum novaLF58 and Bifidobacterium bifidum novaBBF9 affects the gut–myometrium and gut–ovary axes. Intestinal epithelial cells were exposed to individual probiotics or their combination using a Transwell^® setup; their effects on barrier integrity, probiotic activity and short-chain fatty acid production were measured. Subsequently, basolateral metabolites were applied to myometrial and ovarian cells to assess viability, proliferation, oxidative stress, inflammation, signalling pathways and hormone production. All probiotics enhanced intestinal cell viability and barrier function. The combined probiotic showed synergistic effects, enhancing butyrate production by ~23–51%, improving myometrial proliferation by up to ~78%, decreasing ROS and TNF-α levels by ~49% and ~74% and modulating oxytocin signalling. In ovarian cells, the probiotic mixture activated ERK/MAPK and PI3K/AKT pathways, normalised PAK1, ERβ and PAX8 expressions and significantly increased LH and FSH secretion compared to single strains. These findings suggest that a multi-strain probiotic may modulate pathways involved in reproductive tissue homeostasis through gut–reproductive axis interactions, providing mechanistic insight from an in vitro study. Full article